TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Stock

Certificat

DE000SB1PCR2

Delayed Deutsche Boerse AG 03:41:19 2024-05-20 pm EDT
15.16 EUR -2.70% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
Current month-3.83%
1 month-3.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 15.16 -2.70%
24-05-17 15.58 +0.32%
24-05-16 15.53 +2.04%
24-05-15 15.22 +3.82%
24-05-14 14.66 -0.41%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 03:41 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SB1PCR
ISINDE000SB1PCR2
Date issued 2020-06-16
Strike 166.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.12
Lowest since issue 3.77
Spread 0.04
Spread %0.26%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW